Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nancey

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
La Revue Du Praticien|July 19, 2001
[Specific carbohydrate malabsorption]S Nancey, B Flourié
Inflammatory Bowel Diseases|April 19, 2018
Predictive Models of Therapeutic Response to Vedolizumab: A Novel Step into Personalized Medicine in Crohn's Disease?P Veyrard, G Boschetti, S Nancey, et al.
Gastroenterologie Clinique Et Biologique|January 15, 2002
[Colonic microflora and cancer]S Nancey, B Coffin, L Descos, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2017
Letter: thiopurines - is less really more? Authors' replyX Roblin, S Paul, S Nancey, et al.
Clinical and Experimental Dermatology|December 28, 2020
What dermatologists should know about faecal calprotectin to allow adequate interpretation of the results in clinical practiceS Nancey, B Flourié, C Gay, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2013
Letter: mucosal healing in ulcerative colitis--higher relevance than in Crohn's disease? Authors' replyD Laharie, J Filippi, X Roblin, et al.
European Journal of Clinical Nutrition|August 25, 2006
Faecal bacterial mass and energetic losses in healthy humans and patients with a short bowel syndromeL Achour, S Nancey, D Moussata, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2013
Letter: extracorporeal photopheresis in refractory chronic active ulcerative colitisS Nancey, G Boschetti, D Moussata, et al.
Gut|August 7, 2015
A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's diseaseG Boschetti, S Assaad, B Balme, et al.
Annales De Dermatologie Et De Venereologie|April 27, 2004
[Vaccine-induced urticaria: how to differentiate allergy (IgE) from pseudoallergy?]A Catelain, F Cousin, N Freymond, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
La Revue Du Praticien|July 19, 2001
[Specific carbohydrate malabsorption]S Nancey, B Flourié
Inflammatory Bowel Diseases|April 19, 2018
Predictive Models of Therapeutic Response to Vedolizumab: A Novel Step into Personalized Medicine in Crohn's Disease?P Veyrard, G Boschetti, S Nancey, et al.
Gastroenterologie Clinique Et Biologique|January 15, 2002
[Colonic microflora and cancer]S Nancey, B Coffin, L Descos, et al.
Alimentary Pharmacology & Therapeutics|December 12, 2017
Letter: thiopurines - is less really more? Authors' replyX Roblin, S Paul, S Nancey, et al.
Clinical and Experimental Dermatology|December 28, 2020
What dermatologists should know about faecal calprotectin to allow adequate interpretation of the results in clinical practiceS Nancey, B Flourié, C Gay, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2013
Letter: mucosal healing in ulcerative colitis--higher relevance than in Crohn's disease? Authors' replyD Laharie, J Filippi, X Roblin, et al.
European Journal of Clinical Nutrition|August 25, 2006
Faecal bacterial mass and energetic losses in healthy humans and patients with a short bowel syndromeL Achour, S Nancey, D Moussata, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2013
Letter: extracorporeal photopheresis in refractory chronic active ulcerative colitisS Nancey, G Boschetti, D Moussata, et al.
Gut|August 7, 2015
A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's diseaseG Boschetti, S Assaad, B Balme, et al.
Annales De Dermatologie Et De Venereologie|April 27, 2004
[Vaccine-induced urticaria: how to differentiate allergy (IgE) from pseudoallergy?]A Catelain, F Cousin, N Freymond, et al.
Pageof 4